About Evecxia Therapeutics

About company

Evecxia Therapeutics is a privately funded, clinical-stage pharmaceutical company that is dedicated to realizing the therapeutic potential of 5-hydroxytryptophan. It aims to develop and commercialize EVX-101, to treat patients suffering from disabling, common, and costly neuropsychiatric conditions in which current therapies are inadequate, in particular depression. The company was established in 2013 and is based in Raleigh, North Carolina.